HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phisoderm Anti-Acne Extensions To Create Clear Confidence Sub-Brand

This article was originally published in The Rose Sheet

Executive Summary

Chattem will introduce two pHisoderm anti-acne product extensions in early 2002 to create a Clear Confidence sub-brand intended to capitalize on the brand's recent growth in the acne-fighting segment, President Alec Taylor said.

You may also be interested in...



Chattem Acquisition Fund Expected To Reach $40 Mil. With Offering

Chattem is hoping to net approximately $60 mil. from a new share offering that will be used to retire bank debt and fund future acquisitions. Announced June 17, the offering of 1.8 mil. shares is expected to be complete in early July, Chattem said

Chattem Acquisition Fund Expected To Reach $40 Mil. With Offering

Chattem is hoping to net approximately $60 mil. from a new share offering that will be used to retire bank debt and fund future acquisitions. Announced June 17, the offering of 1.8 mil. shares is expected to be complete in early July, Chattem said

Chattem Phisoderm Clear Swabs Launch Will Target “Back-To-School” Crowd

Chattem will back the launch of pHisoderm Clear Swab with dedicated ads and product sampling

Related Content

UsernamePublicRestriction

Register

RS009674

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel